Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.35% |
| 2 | Energy | 10.93% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Financials | 8.18% |
| 5 | Technology | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OCRX
2001
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $1.74M | ﹤0.01% |
549,045
+32,470
| +6% | +$125K |
|
2002
CALL
Opko Health
OPK
$1.02B
| $1.73M | ﹤0.01% |
206,000
-25,000
| -11% | -$331K |
|
2003
iShares Russell 1000 ETF
IWB
$47.1B
| $1.73M | ﹤0.01% |
16,133
+13,686
| +559% | +$1.55M |
|
2004
World Kinect Corp
WKC
$2.06B
| $1.73M | ﹤0.01% |
48,232
-36,998
| -43% | -$1.54M |
|
2005
Enterprise Financial Services Corp
EFSC
$2.4B
| $1.72M | ﹤0.01% |
68,375
+36,306
| +113% | +$870K |
|
2006
PUT
Steel Dynamics
STLD
$36.2B
| $1.72M | ﹤0.01% |
+100,000
| New | +$1.94M |
|
2007
Andersons Inc
ANDE
$2.39B
| $1.72M | ﹤0.01% |
50,421
-17,599
| -26% | -$631K |
|
|
VLRS
2008
Controladora Vuela Compania de Aviacion
VLRS
$869M
| $1.71M | ﹤0.01% |
114,779
+31,306
| +38% | +$430K |
|
2009
Casey's General Stores
CASY
$32.1B
| $1.71M | ﹤0.01% |
16,584
-15,772
| -49% | -$1.64M |
|
|
ENZ
2010
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.7M | ﹤0.01% |
536,658
-241,026
| -31% | -$731K |
|
|
MKTO
2011
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $1.7M | ﹤0.01% |
59,667
-34,870
| -37% | -$984K |
|
|
CSR
2012
Centerspace
CSR
$952M
| $1.69M | ﹤0.01% |
+21,875
| New | +$1.56M |
|
2013
CALL
Rio Tinto
RIO
$152B
| $1.69M | ﹤0.01% |
+50,000
| New | +$1.87M |
|
|
WWE
2014
PUT
DELISTED
World Wrestling Entertainment
WWE
| $1.69M | ﹤0.01% |
+100,000
| New | +$1.87M |
|
2015
Helios Technologies
HLIO
$2.47B
| $1.69M | ﹤0.01% |
+61,414
| New | +$2.01M |
|
|
SUP
2016
DELISTED
Superior Industries International
SUP
| $1.69M | ﹤0.01% |
90,219
+77,867
| +630% | +$1.43M |
|
2017
Kearny Financial
KRNY
$604M
| $1.68M | ﹤0.01% |
+146,800
| New | +$1.68M |
|
|
TRR
2018
DELISTED
Trc Companies
TRR
| $1.68M | ﹤0.01% |
141,979
+121,833
| +605% | +$1.25M |
|
|
INFO
2019
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $1.68M | ﹤0.01% |
57,750
-402,026
| -87% | -$11.2M |
|
|
HZNP
2020
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.68M | ﹤0.01% |
84,510
-259,701
| -75% | -$8.21M |
|
2021
Morningstar
MORN
$7.55B
| $1.67M | ﹤0.01% |
20,855
+8,332
| +67% | +$680K |
|
|
STML
2022
DELISTED
Stemline Therapeutics, Inc.
STML
| $1.67M | ﹤0.01% |
189,480
-159,500
| -46% | -$1.67M |
|
2023
CALL
State Street SPDR S&P Metals & Mining ETF
XME
$3.75B
| $1.67M | ﹤0.01% |
+100,000
| New | +$1.99M |
|
2024
Franco-Nevada
FNV
$41.3B
| $1.67M | ﹤0.01% |
+37,939
| New | +$1.63M |
|
2025
Eaton
ETN
$141B
| $1.67M | ﹤0.01% |
32,533
-351,083
| -92% | -$20.7M |
|
Similar funds
Millennium Management's Q3 2015 Portfolio in Review
As of Q3 2015, Millennium Management held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Millennium Management deployed $5.12B of net new capital in Q3 2015, opening 840 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, down from 14% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Millennium Management's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Millennium Management added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Millennium Management's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Millennium Management fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Millennium Management's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Millennium Management opened 840 new positions and closed 681 in Q3 2015.
- Millennium Management's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.